The Latin American IVD Market is expected to register a CAGR of 5.5% during the forecast period 2023–2030 to reach $6.45 billion by 2030. The burden of communicable and non-communicable diseases, the rise in medical tourism, the shift toward decentralized testing, and growing awareness regarding early disease diagnosis are driving the growth of this market.
In addition, the inclination toward personalized healthcare and advances in genomics and proteomics offer opportunities for the IVD market. However, the regulatory scenarios in LATAM countries are posing a challenge to the growth of this market.
Diagnosis is crucial for precision medicine to screen patients for breakthrough therapies and detect certain conditions, such as cancer, at an earlier stage. Personalized medicines for infectious diseases help orient the molecular management of infections.
The Personalized Health Index is a first-of-its-kind, data-driven policy tool that measures each country's progress toward the personalized future of healthcare. Uruguay held the first position in the Personalized Health Index for Latin America. Also, according to the Latin American Personalized Medicine Index, Mexico is one of the top five Latin American countries with the best conditions to integrate and promote personalized medicine.
Latin America performs best in personalized technologies such as devices, applications, and reimbursement structures that help drive personalized healthcare in the region. The countries in Latin America are progressing toward the adoption of personalized healthcare and medicine, providing opportunities for the IVD market in the region.
Click here to: Get a Free Sample Copy of this report
Growing Prevalence of Chronic and Infectious Diseases in the Region
Chronic infectious diseases caused by bacterial and viral pathogens are rising in Latin American countries due to various factors, including changes in climatic conditions, increased human population growth & density in urban & rural areas, increased human migration & mobility, and poor public health resources. The pathogenic agents that cause emerging and re-emerging diseases in Latin America include bacterial pathogens (Salmonella enteritidis, Salmonella typhimurium, Salmonella typhi, Brucellaabortus, and Klebsiella pneumonia) and viral pathogens (HPV, HIV, EBV, Zika, and Chikungunya).
According to UNAIDS, the number of adults and children living with HIV in the Latin American region reached 2,100,000 in 2020 from 2,000,000 in 2018. The number of annual new infections has continued to rise in the region. Furthermore, the outbreak of COVID-19 disease had affected a large population in the region and spread continuously throughout the region. Apart from infectious diseases, non-communicable diseases (NCDs), including cancer, are the leading cause of preventable and premature deaths in Latin America. In 2020, cancer cases in Latin America were 1.47 million, which is estimated to reach 1.93 million by 2030 and 2.44 million by 2040 (Source: GLOBCAN)
This increase in the number of diseases in the region is fueling the growth of the Latin America IVD market.
Based on Product & Solution, the Kits & Reagents Segment is Expected to Register the Highest CAGR during the Forecast Period
Factors such as the increasing prevalence of infectious diseases in the region and the increasing use of kits & reagents to identify the organism causing various diseases in less time and cost contribute to the high growth of this market. Furthermore, the outbreak of COVID-19 disease accelerated the growth of this segment due to the national emergency and the requirement of various kits & assays for early disease diagnosis.
Based on Technology, the Molecular Diagnostics Segment is Expected to Account for the Largest Share of Latin America In Vitro Diagnostics Market
The high prevalence of infectious diseases, advantages of molecular diagnostics techniques such as high sensitivity and accuracy, and rising penetration of advanced molecular techniques are factors driving the growth of this segment.
Based on Diagnostic Approach, the Lab Testing Segment is Estimated to Account for the Largest Share in 2023
The lab testing approach for IVD has higher accuracy and reliability than point-of-care testing. The laboratory equipment and analyzers have high sensitivity and specificity. The lab testing segment is expected to account for the largest share of the Latin America IVD market due to its higher accuracy and reliability, lower costs, availability of several IVD tests, and quality assurance program.
Based on End User, the Hospitals & Clinics are Estimated to Account for the Largest Share in 2023
Hospitals & Clinics can increase the economies of scale and maximize the usage of equipment and staff while not reducing the level of service. Due to this reason, hospital laboratories are one of the major end users for IVD in Latin America.
Brazil is Expected to Dominate the Latin American IVD Market
Factors such as well-established healthcare infrastructure, growing healthcare expenditure, rising demand for genetic testing, increasing awareness about the use of IVD products, and growing awareness for cancer screening are responsible for the growth of this segment.
Key Players
The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments in leading industry market players over the past three to four years. The key players operating in the IVD market in Latin America are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Qiagen N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Wama Diagnóstica (Brazil), and Wiener Laboratorios SAIC (Argentina)
Scope of the Report:
Latin America In Vitro Diagnostics Market Assessment, by Product & Solution
Latin America In Vitro Diagnostics Market Assessment, by Technology
Latin America In Vitro Diagnostics Market Assessment, by Application
Latin America In Vitro Diagnostics Market Assessment, by Diagnostic Approach
Latin America In Vitro Diagnostics Market Assessment, by End User
Latin America In Vitro Diagnostics Market Assessment, by Country
Key questions answered in the report-
The Latin America in vitro diagnostics market covers the market size & forecasts of reagents, kits, assays, instruments/analyzers, and software/services used to diagnose diseases. Latin America in vitro diagnostics market studied in this report involves the value analysis of various segments and sub-segments of in vitro diagnostics at the country level.
The Latin America in vitro diagnostics market is projected to reach $6.45 billion by 2030, at a CAGR of 5.5% during the forecast period.
Based on products & solutions, the kits & reagents segment is estimated to account for the largest share of the Latin America in vitro diagnostics market in 2023. Factors such as the increasing prevalence of infectious diseases in the region and the increasing use of kits & reagents to identify the organism causing various diseases in less time and cost contribute to the high growth of this market.
Based on application, the cardiology segment is expected to grow at the fastest CAGR during the forecast period due to the increasing prevalence of various cardiovascular diseases and new innovative product launches for the cardiology segment.
Based on technology, the molecular diagnostics segment held the largest market share due to its advantages, such as high sensitivity and accuracy, high adoption, and high prevalence of infectious diseases in the region.
The growth of the in vitro diagnostics market in the region is attributed to the growing prevalence of communicable and non-communicable diseases, growing medical tourism, adoption of point of care testing, and growing awareness regarding early disease diagnosis. On the other hand, the inclination towards personalized healthcare and advances in genomics and proteomics offer opportunities for the IVD market in Latin America.
The key players operating in the IVD market in Latin America are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Qiagen N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Wama Diagnóstica (Brazil), and Wiener Laboratorios SAIC (Argentina).
Countries such as Brazil, Argentina, Peru, Colombia, and Chile are projected to offer significant growth opportunities to the vendors in this market due to their well-established healthcare infrastructure and growing healthcare expenditure.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Dynamics
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Communicable and Non-communicable Diseases
4.2.2. Growing Awareness Regarding Early Disease Diagnosis
4.2.3. Adoption of Point-of-care Testing
4.2.4. Expanding Medical Tourism in the Region
4.3. Opportunities
4.3.1. Inclination Toward Personalized Healthcare or Personalized Medicine
4.3.2. Advancements in Genomics and Proteomics
4.4. Challenges
4.4.1. Regulatory Scenario in Latin American Countries
5. Latin America In Vitro Diagnostics Market Assessment—by Product & Solution
5.1. Overview
5.2. Reagents & Kits
5.3. Instruments
5.4. Software & Services
6. Latin America In Vitro Diagnostics Market Assessment—by Technology
6.1. Overview
6.2. Molecular Diagnostics
6.3. Point-of-Care (PoC) Diagnostics
6.4. Immunoassay/Immunochemistry
6.5. Biochemistry/Clinical Chemistry
6.6. Whole Blood Glucose Monitoring
6.7. Hematology
6.8. Microbiology
6.9. Coagulation & Hemostasis
6.10. Urinalysis
6.11. Other IVD Technologies
7. Latin America In Vitro Diagnostics Market Assessment—by Application
7.1. Overview
7.2. Infectious Diseases
7.3. Oncology
7.4. Cardiology
7.5. Diabetes
7.6. Autoimmune Disorders
7.7. Nephrology
7.8. Other Applications
8. Latin America In Vitro Diagnostics Market Assessment—by Diagnostic Approach
8.1. Overview
8.2. Lab Testing
8.3. OTC/Self-testing
8.4. Point-of-care Testing
9. Latin America In Vitro Diagnostics Market Assessment—by End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Home Healthcare
9.5. Other End Users
10. Latin America In Vitro Diagnostics Market Assessment—by Country
10.1. Overview
10.2. Brazil
10.3. Mexico
10.4. Argentina
10.5. Colombia
10.6. Peru
10.7. Chile
10.8. Ecuador
10.9. Uruguay
10.10. Dominican Republic
10.11. Paraguay
10.12. Bolivia
10.13. Rest of Latin America
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.5. Market Share Analysis (2022)
11.5.1. F. Hoffmann-La Roche Ltd (Switzerland)
11.5.2. Abbott Laboratories (U.S.)
11.5.3. Danaher Corporation (U.S.)
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. bioMérieux SA
12.4. Danaher Corporation
12.5. F. Hoffmann-La Roche Ltd.
12.6. QIAGEN N.V.
12.7. Siemens Healthineers AG (A Subsidiary of Siemens AG)
12.8. Thermo Fisher Scientific, Inc.
12.9. Wama Diagnóstica
12.10. Wiener Laboratorios SAIC
(Note: SWOT Analysis of Top 5 Companies Will be Provided)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Latin America: Number of New HIV Cases by Country (2019 Vs. 2020 Vs. 2021)
Table 2 Latin America: Medical Tourism Destinations
Table 3 Latin America: Medical Tourism Index and Rankings (2020–2021)
Table 4 Personalized Health Index: Latin America
Table 5 Latin America In Vitro Diagnostics (IVD) Market, by Product & Solution, 2021–2030 (USD Million)
Table 6 Latin America IVD Reagents & Kits Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Latin America IVD Instruments Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Price of IVD Instruments in Latin America, 2021
Table 9 Latin America IVD Software & Services Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 11 Latin America Molecular Diagnostics Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Latin America Point-of-care (PoC) Diagnostics Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Latin America Immunoassay/Immunochemistry Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Latin America Biochemistry/Clinical Chemistry Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Latin America Whole Blood Glucose Monitoring Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Latin America Hematology Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Latin America IVD Market for Microbiology, by Country/Region, 2021–2030 (USD Million)
Table 18 Latin America Coagulation and Hemostasis Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Latin America Urinalysis Market, by Country/Region, 2021–2030 (USD Million)
Table 20 Latin America Other IVD Technologies Market, by Country/Region, 2021–2030 (USD Million)
Table 21 Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 22 Covid-19 Cases & Mortalities in Latin America (As of June 2023)
Table 23 Latin America: Number of HIV Cases (Adults & Children), by Country ‘2019’ and ‘2020’
Table 24 Technologies and their Applications in Various Infectious Diseases
Table 25 Latin America In Vitro Diagnostics Market for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 26 Latin America: Cancer Cases, by Country (2020 Vs. 2030)
Table 27 Latin America In Vitro Diagnostics Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 28 Latin America: Deaths Due to Cardiovascular Diseases, by Country (2019)
Table 29 Latin America In Vitro Diagnostics Market for Cardiology, by Country/Region, 2021–2030 (USD Million)
Table 30 Latin America: Diabetes Cases, by Country (2021 Vs. 2030)
Table 31 Latin America In Vitro Diagnostics Market for Diabetes, by Country/Region, 2021–2030 (USD Million)
Table 32 Latin America In Vitro Diagnostics Market for Autoimmune Disorders, by Country/Region, 2021–2030 (USD Million)
Table 33 Latin America In Vitro Diagnostics Market for Nephrology, by Country/Region, 2021–2030 (USD Million)
Table 34 Latin America In Vitro Diagnostics Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 35 Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 36 Latin America In Vitro Diagnostics Market for Lab Testing, by Country/Region, 2021–2030 (USD Million)
Table 37 Latin America In Vitro Diagnostics Market for OTC/Self-testing, by Country/Region, 2021–2030 (USD Million)
Table 38 Latin America In Vitro Diagnostics Market for Point-of-care Testing, by Country/Region, 2021–2030 (USD Million)
Table 39 Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 40 Top Ranking Hospitals in Latin America
Table 41 Latin America In Vitro Diagnostics Market for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 42 Latin America In Vitro Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
Table 43 Latin America In Vitro Diagnostics Market for Home Healthcare, by Country/Region, 2021-2030 (USD Million)
Table 44 Latin America In Vitro Diagnostics Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
Table 45 Latin America In Vitro Diagnostic Market, by Country/Region, 2021–2030 (USD Million)
Table 46 Latin America: Latin America In Vitro Diagnostics Market, by Product and Solution, 2021–2030 (USD Million)
Table 47 Latin America: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 48 Latin America: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 49 Latin America: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 50 Latin America: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 51 Testing Initiatives for Covid-19 in Brazil
Table 52 Brazil: Macroindicators
Table 53 Brazil: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 54 Brazil: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 55 Brazil: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 56 Brazil: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 57 Brazil: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 58 Mexico: Some of the Serological Tests Approved by the National Institute And Reference “Dr. Manuel Martínez Báez” (Indre) Against COVID-19
Table 59 Mexico: Macroindicators
Table 60 Mexico: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 61 Mexico: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 62 Mexico: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 63 Mexico: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 64 Mexico: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 65 Argentina: Macroindicators
Table 66 Argentina: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 67 Argentina: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 68 Argentina: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 69 Argentina: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 70 Argentina: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 71 Colombia: Macroindicators
Table 72 Colombia: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 73 Colombia: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 74 Colombia: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 75 Colombia: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 76 Colombia: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 77 Peru: Macroindicators
Table 78 Peru: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 79 Peru: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 80 Peru: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 81 Peru: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 82 Peru: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 83 Chile: Macroindicators
Table 84 Chile: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 85 Chile: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 86 Chile: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 87 Chile: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 88 Chile: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 89 Ecuador: Macroindicators
Table 90 Ecuador: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 91 Ecuador: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 92 Ecuador: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 93 Ecuador: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 94 Ecuador: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 95 Uruguay: Macroindicators
Table 96 Uruguay: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 97 Uruguay: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 98 Uruguay: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 99 Uruguay: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 100 Uruguay: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 101 Dominican Republic: Macroindicators
Table 102 Dominican Republic: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 103 Dominican Republic: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 104 Dominican Republic: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 105 Dominican Republic: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 106 Dominican Republic: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 107 Paraguay: Macroindicators
Table 108 Paraguay: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 109 Paraguay: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 110 Paraguay: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 111 Paraguay: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 112 Paraguay: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 113 Bolivia: Top 5 Causes of Deaths (2020)
Table 114 Bolivia: Macroindicators
Table 115 Bolivia: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 116 Bolivia: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 117 Bolivia: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 118 Bolivia: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 119 Bolivia: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 120 Rest of Latin America: Macroindicators
Table 121 Rest of Latin America: Latin America In Vitro Diagnostics Market, by Product & Solution, 2021–2030 (USD Million)
Table 122 Rest of Latin America: Latin America In Vitro Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 123 Rest of Latin America: Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 124 Rest of Latin America: Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 125 Rest of Latin America: Latin America In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 126 Recent Developments, by Company, 2020–2023
Table 127 Becton, Dickinson, and Company (Bd): Subsidiaries in Latin America
Table 128 F. Hoffmann-La Roche Ltd: Subsidiaries and Associates in Latin America
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Latin America In Vitro Diagnostics Market, by Product & Solution, 2023 Vs. 2030 (USD Million)
Figure 8 Latin America In Vitro Diagnostics Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Latin America In Vitro Diagnostics Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Latin America In Vitro Diagnostics Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Latin America In Vitro Diagnostics Market, by Country/Region
Figure 12 Market Dynamics
Figure 13 Latin America In Vitro Diagnostics (IVD) Market, by Product & Solution, 2021–2030 (USD Million)
Figure 14 Latin America In Vitro Diagnostics Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 15 Adult Population (20–79 Years) with Diabetes in Latin American Countries (Million) (2021)
Figure 16 Latin America In Vitro Diagnostics Market, by Application, 2021–2030 (USD Million)
Figure 17 Latin America: Estimated Number of New Cancer Cases (2020–2040)
Figure 18 Diabetes Prevalence in the South and Central America Region
Figure 19 Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2021–2030 (USD Million)
Figure 20 Benefits of the Lab Testing Approach
Figure 21 Benefits of Point-of-care Testing Approach
Figure 22 Latin America In Vitro Diagnostics Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 23 Latin America In Vitro Diagnostics Market: Snapshot
Figure 24 Brazil In Vitro Diagnostics Market: Challenges
Figure 25 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 26 Latin America In Vitro Diagnostics Market: Competitive Benchmarking
Figure 27 Market Share Analysis: Latin America In Vitro Diagnostics Industry, 2022
Figure 28 Abbott Laboratories: Financial Overview (2022)
Figure 29 Becton, Dickinson and Company: Financial Overview (2022)
Figure 30 bioMérieux SA: Financial Overview (2022)
Figure 31 Danaher Corporation: Financial Overview (2022)
Figure 32 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)
Figure 33 QIAGEN N.V.: Financial Overview
Figure 34 Siemens Healthineers AG: Financial Overview (2022)
Figure 35 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Feb-2024
Published Date: Jan-2024
Published Date: Nov-2023
Published Date: Aug-2023
Published Date: Jul-2023
